Literature DB >> 24784863

Serum lipids and lipoproteins in patients with psoriasis.

Mehdi Taheri Sarvtin1, Mohammad Taghi Hedayati2, Tahereh Shokohi2, Zohreh HajHeydari3.   

Abstract

BACKGROUND: Psoriasis is a common chronic and recurrent inflammatory skin disorder characterized by hyperproliferation of keratinocytes and infiltration of T cells, monocytes/macrophages and neutrophils into dermal and epidermal layers of the skin. The prevalence of cardiovascular disorders in these patients is remarkably higher compared to normal individuals, which seems to be associated with the hyperlipidemia. This study was designed and conducted to investigate the serum lipid profile in psoriatic patients and its association with the severity of disease. MATHERIALS AND METHODS: This case-control study was performed on 50 plaque-type psoriasis patients and 50 healthy individuals as control, matched for age and sex. Blood samples were collected after 14 h fasting. Serum triglyceride, cholesterol and lipoproteins were assayed using the standard kit (made by Pars Azmon Co. Iran).
RESULTS: Certain parameters, including serum triglyceride, cholesterol, low density lipoprotein (LDL), and very low density lipoprotein (VLDL), were significantly higher in the case group compared to the controls (P < 0.001), while high density lipoprotein (HDL) was significantly lower in the former (P < 0.001). In addition, there was a significant relationship between severity of psoriasis and serum lipid profile.
CONCLUSION: The results have revealed the higher plasma level of lipids in psoriatic patients. This may elevate the risk of atherosclerosis, particularly cardiovascular disorders. Therefore, from the epidemiological point of view, screening psoriatic patients, particularly those with severe psoriasis, is recommended.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24784863     DOI: 0141705/AIM.007

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  8 in total

1.  Ozonated autohemotherapy elevates PPAR-γ expression in CD4+ T cells and serum HDL-C levels, a potential immunomodulatory mechanism for treatment of psoriasis.

Authors:  Jinrong Zeng; Zhen Tang; Yuezhong Zhang; Xiaoliang Tong; Jianhua Dou; Lihua Gao; Shu Ding; Jianyun Lu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Welch-weighted Egger regression reduces false positives due to correlated pleiotropy in Mendelian randomization.

Authors:  Brielin C Brown; David A Knowles
Journal:  Am J Hum Genet       Date:  2021-12-02       Impact factor: 11.043

3.  The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study.

Authors:  Fahimeh Rezazadeh; Maryam Moshaverinia; Farhad Handjani; Fatemeh Khoshkholgh; Nasrin Saki; Alireza Heiran
Journal:  Malays J Med Sci       Date:  2020-04-30

4.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406

5.  Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis.

Authors:  Lenka Borska; Jan Kremlacek; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Pavel Borsky; Vladimir Palicka; Vit Rehacek; Andrea Malkova; Zdenek Fiala
Journal:  Int J Mol Sci       Date:  2017-10-25       Impact factor: 5.923

6.  Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry.

Authors:  Li Li; Lu Chuan-Jian; Han Ling; Deng Jing-Wen; He Ze-Hui; Yan Yu-Hong; Zhang Zhong-Zhao
Journal:  Oncotarget       Date:  2017-10-06

7.  Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients.

Authors:  Seraj Ahmed Khan; Sudha Agrawal; Nirmal Baral; Madhab Lamsal
Journal:  Psoriasis (Auckl)       Date:  2018-09-04

8.  Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies.

Authors:  Mazaher Ramezani; Elisa Zavattaro; Masoud Sadeghi
Journal:  Postepy Dermatol Alergol       Date:  2019-12-30       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.